Published in Acta Leiden on January 01, 1991
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med (1995) 3.67
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med (2005) 2.10
Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology (1997) 1.45
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
Functional and morphological monocyte abnormalities in a patient with malakoplakia. Am J Med (1998) 0.91
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest (2001) 0.86
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol (1989) 0.81
Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology (1985) 0.80
Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol (1998) 0.80
Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis? Acta Leiden (1988) 0.79
Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect Immun (1982) 0.78
Malarial immunity in pregnant mice, in relation to total and unbound plasma corticosterone. Bull Soc Pathol Exot Filiales (1983) 0.77
Stage-specific proteins of Plasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum. Parasitol Res (1988) 0.77
Cerebral lesions in mice infected with Plasmodium berghei are the result of an immunopathological reaction. Trans R Soc Trop Med Hyg (1989) 0.76
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice. Parasitology (1999) 0.76
Impaired immune responsiveness in Plasmodium berghei immune mice. Parasite Immunol (1989) 0.76
Attenuated immunogenic parasites are essential in the transfer of immunity to virulent Plasmodium berghei. Immunology (1995) 0.75
Murine malaria. II. Relationship between number of inoculated parasites (Plasmodium berghei) and survival time. Exp Parasitol (1971) 0.75
ACTH-dependent modulation of malaria immunity in mice. Parasite Immunol (1985) 0.75
Murine malaria. I. Measurement of the mean rate of increase in vivo of Plasmodium berghei. Exp Parasitol (1971) 0.75